KRAS and metastatic neoplasm: This is in accordance with a previous molecular study of matched tumor pairs/trios of colorectal cancer patients with ovarian metastases, suggesting that mutated <i>KRAS</i> is a universal driver of the metastatic disease in women with <i>KRAS</i>-mutated colorectal cancer with ovarian metastases.